KIMBERLY-CLARK TO BUY TYLENOL MAKER KENVUE IN LANDMARK $40BN MERGER
https://media.zenfs.com/en/the_guardian_765/d22535b761aec5f2c586aac6ac4a98f1
✍️ Kimberly-Clark has announced plans to buy Kenvue, the consumer health conglomerate behind Tylenol, in a deal worth over $40bn.
👉 Kimberly-Clark to acquire Kenvue in a deal worth over $40bn 👉 Kenvue has faced declining stock prices and lawsuits over claims of product harm 👉 Tylenol has been at the center of controversy over claims of autism risk 👉 Kimberly-Clark expects $2.1bn in annual cost savings from the acquisition
-- #MikeHsu #LarryMerlo #RobertFKennedyJr #DonaldTrump #Irving,Texas #Brazil #business
Loading quoted post…
